- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Obesity & Type 2 Diabetes: Early Intervention Critical in Reducing Risk for Complications
Early intervention is important to reduce the risk for complications for patients with obesity and type 2 diabetes. Two obesity experts explain more, here.
What are the most significant complications associated with obesity and type 2 diabetes that a primary care clinician is likely to encounter?
That was a question Patient Care Online asked 2 obesity experts, Shagun Bindlish, MD, and Peminda K. Cabandugama, MD. Dr Bindlish is a board member of the American Diabetes Association and medical director at One Medical in Dublin, California. Dr Cabandugama is the director of Digital Obesity at the Cleveland Clinic and a member of the Obesity Medicine Association.
Find out their answers and explanations in the video below.
Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial
August 26th 2025Patients taking orforglipron achieved significant weight loss, hemoglobin A1c reduction, and cardiometabolic benefits in the phase 3 ATTAIN-2 study, supporting upcoming global regulatory submissions.
